This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: David Lehman - Innovator in Medicinal Chemistry
Introduction
David Lehman is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on novel compounds.
Latest Patents
David Lehman holds a patent for trans-3-aza-bicyclo[3.1.0]hexane derivatives. This invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n, and R are as described in the description. The patent emphasizes the use of such compounds, or their pharmaceutically acceptable salts, as medicaments, especially as orexin receptor antagonists. He has 1 patent to his name.
Career Highlights
David Lehman is associated with Actelion Pharmaceuticals Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work has contributed to the understanding and application of innovative medicinal compounds.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Markus Gude and Thierry Sifferlen. These collaborations have fostered a productive environment for innovation and discovery in the pharmaceutical industry.
Conclusion
David Lehman's contributions to medicinal chemistry and his innovative patent work highlight his role as a significant inventor in the field. His dedication to advancing pharmaceutical science continues to impact the industry positively.